IDH1 and neoplasm: Recently, the same model described above that demonstrated high accuracy in detecting IDH mutation status also was used to detect and segment the MGMT promoter methylated tumor on MRI with an accuracy of 94.73%, sensitivity of 96.31%, specificity of 91.66%, and mean AUC of 93%.